Literature DB >> 18842745

Increased acoustic startle responses in IBS patients during abdominal and nonabdominal threat.

Bruce D Naliboff1, Allison M Waters, Jennifer S Labus, Lisa Kilpatrick, Michelle G Craske, Lin Chang, Hideki Negoro, Hana Ibrahimovic, Emeran A Mayer, Edward Ornitz.   

Abstract

BACKGROUND AND AIMS: Visceral hypersensitivity and symptom severity in Irritable Bowel Syndrome (IBS) are both exacerbated by stress. The eye-blink startle response represents a noninvasive measure of central defensive responding. Evidence for central hyperexcitability was studied in IBS patients by examining potentiation of the startle reflex to a nociceptive threat.
METHODS: Acoustic startle responses were examined in female IBS patients (n = 42) and healthy controls (n = 22) during cued periods in which an aversive abdominal or biceps stimulation was impossible (safe), possible (imminent threat) or anticipated (period just before the imminent threat), and during a threatening context (muscle stimulation pads attached but no cues for stimulation).
RESULTS: Both groups showed potentiation of startle responses during the imminent threat condition compared with both the anticipation and safe conditions. Compared with controls, IBS subjects showed significantly larger startle responses during anticipation and imminent threat conditions after receiving an initial aversive stimulation. There were no group differences during the context threat manipulation. Moreover, in IBS patients but not controls, higher neuroticism was associated with larger startle responses during safe and anticipation conditions but not imminent threat, whereas anxiety symptoms were negatively associated with startle magnitude during imminent threat.
CONCLUSIONS: Female IBS patients show increased startle responses to threat of aversive stimulation at both abdominal and nonabdominal sites compared with controls. The data represent the first demonstration of altered threat potentiated startle in a functional pain condition and provide support for the use of these paradigms in further evaluation of affective mechanisms in these disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18842745      PMCID: PMC4104120          DOI: 10.1097/PSY.0b013e318186d858

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  30 in total

1.  The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle.

Authors:  Christian Grillon; Johanna M P Baas; Daniel S Pine; Shmuel Lissek; Megan Lawley; Valerie Ellis; Jessica Levine
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

2.  Affective modulation of nociception at spinal and supraspinal levels.

Authors:  Jamie L Rhudy; Amy E Williams; Klanci M McCabe; Mary Anh Thù V Nguyen; Philip Rambo
Journal:  Psychophysiology       Date:  2005-09       Impact factor: 4.016

Review 3.  Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders.

Authors:  Emeran A Mayer; Bruce D Naliboff; A D Bud Craig
Journal:  Gastroenterology       Date:  2006-12       Impact factor: 22.682

4.  Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients.

Authors:  Bruce D Naliboff; Steve Berman; Brandall Suyenobu; Jennifer S Labus; Lin Chang; Jean Stains; Mark A Mandelkern; Emeran A Mayer
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

5.  The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.

Authors:  Jennifer S Labus; Emeran A Mayer; Lin Chang; Roger Bolus; Bruce D Naliboff
Journal:  Psychosom Med       Date:  2007-01       Impact factor: 4.312

Review 6.  Peripheral and central contributions to hyperalgesia in irritable bowel syndrome.

Authors:  Donald D Price; QiQi Zhou; Baharak Moshiree; Michael E Robinson; G Nicholas Verne
Journal:  J Pain       Date:  2006-08       Impact factor: 5.820

7.  Sex specific alterations in autonomic function among patients with irritable bowel syndrome.

Authors:  K Tillisch; E A Mayer; J S Labus; J Stains; L Chang; B D Naliboff
Journal:  Gut       Date:  2005-05-28       Impact factor: 23.059

8.  Effect of sex on perception of rectosigmoid stimuli in irritable bowel syndrome.

Authors:  Lin Chang; Emeran A Mayer; Jennifer S Labus; Max Schmulson; Oh Young Lee; Teresa I Olivas; Jean Stains; Bruce D Naliboff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-03-30       Impact factor: 3.619

9.  Evidence for two distinct perceptual alterations in irritable bowel syndrome.

Authors:  B D Naliboff; J Munakata; S Fullerton; R H Gracely; A Kodner; F Harraf; E A Mayer
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

10.  Fear-potentiated startle conditioning in humans: explicit and contextual cue conditioning following paired versus unpaired training.

Authors:  C Grillon; M Davis
Journal:  Psychophysiology       Date:  1997-07       Impact factor: 4.016

View more
  19 in total

1.  Healing Words: Using Affect Labeling to Reduce the Effects of Unpleasant Cues on Symptom Reporting in IBS Patients.

Authors:  Elena Constantinou; Katleen Bogaerts; Lukas Van Oudenhove; Jan Tack; Ilse Van Diest; Omer Van den Bergh
Journal:  Int J Behav Med       Date:  2015-08

2.  Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations.

Authors:  Eric L Garland; Susan A Gaylord; Olafur Palsson; Keturah Faurot; J Douglas Mann; William E Whitehead
Journal:  J Behav Med       Date:  2011-12-08

3.  Importance of trauma-related fear in patients with irritable bowel syndrome and early adverse life events.

Authors:  Harman Rahal; Elizabeth J Videlock; Adriane Icenhour; Wendy Shih; Bruce Naliboff; Arpana Gupta; Emeran A Mayer; Lin Chang
Journal:  Neurogastroenterol Motil       Date:  2020-06-17       Impact factor: 3.598

Review 4.  Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.

Authors:  Jennifer S Labus; Catherine S Hubbard; Joshua Bueller; Bahar Ebrat; Kirsten Tillisch; Michelle Chen; Jean Stains; George E Dukes; Dennis L Kelleher; Bruce D Naliboff; Michael Fanselow; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-08-14       Impact factor: 22.682

5.  Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain.

Authors:  Catherine S Hubbard; Jennifer S Labus; Joshua Bueller; Jean Stains; Brandall Suyenobu; George E Dukes; Dennis L Kelleher; Kirsten Tillisch; Bruce D Naliboff; Emeran A Mayer
Journal:  J Neurosci       Date:  2011-08-31       Impact factor: 6.167

6.  Sex-related differences in prepulse inhibition of startle in irritable bowel syndrome (IBS).

Authors:  L A Kilpatrick; E Ornitz; H Ibrahimovic; M Treanor; M Craske; M Nazarian; J S Labus; E A Mayer; B D Naliboff
Journal:  Biol Psychol       Date:  2010-03-01       Impact factor: 3.251

Review 7.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

8.  Elevated responding to safe conditions as a specific risk factor for anxiety versus depressive disorders: evidence from a longitudinal investigation.

Authors:  Michelle G Craske; Kate B Wolitzky-Taylor; Susan Mineka; Richard Zinbarg; Allison M Waters; Suzanne Vrshek-Schallhorn; Alyssa Epstein; Bruce Naliboff; Edward Ornitz
Journal:  J Abnorm Psychol       Date:  2011-10-10

9.  Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain.

Authors:  Lee Tran; Jay Schulkin; Beverley Greenwood-Van Meerveld
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

10.  Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response.

Authors:  Alexa Orand; Bruce Naliboff; Malin Gadd; Wendy Shih; Tiffany Ju; Angela P Presson; Emeran A Mayer; Lin Chang
Journal:  Psychoneuroendocrinology       Date:  2016-07-19       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.